GURU.Markets stock price, segment price, and overall market index valuation
The company's share price TransMedics Group
TransMedics Group has revolutionized transplantation with its warm organ transport system. Its stock price reflects the rapid growth of this technology in hospitals, saving more lives and improving transplant outcomes.
Share prices of companies in the market segment - Specialized medical equipment
TransMedics revolutionized the transplant sector by creating a system for "reviving" donor organs outside the body. We classify the company as a Specialized Medical Equipment company, and the chart below shows the overall performance of this segment.
Broad Market Index - GURU.Markets
TransMedics is a medical company that has developed a unique system for transporting living donor organs (heart, lungs, liver). As part of the GURU.Markets index, it is revolutionizing transplantation. The chart below represents the entire market. See how this innovator's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
TMDX - Daily change in the company's share price TransMedics Group
The daily price change of TransMedics, the creator of a system for transporting donor organs, reflects breakthroughs in transplantation. Change_co shows high sensitivity to news and regulatory approvals. This metric is important for analyzing volatility in the innovative medical equipment sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
TransMedics Group, Inc. is a company that has developed a system for "reviving" donor organs. This chart illustrates the extreme volatility of the MedTech sector. A comparison with the performance of TMDX, whose technology is revolutionizing transplantation, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
TransMedics is an innovative medical company that has developed a system for "warm" perfusion of donor organs, increasing their viability. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how TransMedics' stock is responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization TransMedics Group
TransMedics has developed a revolutionary technology for organ donation. Its year-over-year performance reflects its rapid growth and the adoption of its technology in clinical practice. The chart below tells the story of this leading medical technology company.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
TransMedics Group, Inc. has revolutionized organ transplantation with its system that keeps organs alive outside the body. Its technology expands the pool of available organs. This chart shows how its breakthrough innovations and growth potential in this critical area of medicine are impacting its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
TransMedics, with its revolutionary system for "reviving" donor organs, is a breakthrough growth story in medicine. Its stock price is driven by the speed of hospital adoption, not the state of the economy. The chart is a bet on a technology that could fundamentally change transplantation.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization TransMedics Group
TransMedics, an organ transplant company, depends on its operational progress for its market value. Monthly fluctuations on the chart reflect the growth in the number of procedures using its organ transport system, a key indicator of the adoption of its revolutionary technology in medical practice.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
TransMedics Group is revolutionizing transplantation with its system for reviving donor organs outside the body. This technology has the potential to radically change the market. The chart below shows the overall dynamics in the specialized medical equipment sector, allowing one to assess how the market is responding to such breakthrough, yet capital-intensive, innovations.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Disruptive medical technology stocks are a story of high growth, but also of high sensitivity to market risk. The chart below shows the overall investor appetite. Is TransMedics Group moving in sync with the market's growth, or is its success in implementing transplant technology creating its own trend?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization TransMedics Group
TransMedics Group has developed a technology for "reviving" donor organs, making its shares extremely news-sensitive. Weekly price fluctuations reflect clinical trial data, regulatory decisions to expand the use of the technology, and news about hospital partnerships.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
The innovative medical equipment sector, which includes TransMedics, is driven by expectations of breakthrough technologies. The chart below reflects the general sentiment in this niche. It helps us understand how unique and promising the market perceives TransMedics' organ transportation technology compared to other companies' developments.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
TransMedics Group has developed a "warm" perfusion technology for preserving donor organs. This is a breakthrough medical innovation. The chart will show how its shares perform within their own news cycle, responding to regulatory approvals and implementation data, independent of overall market movements.
Market capitalization of the company, segment and market as a whole
TMDX - Market capitalization of the company TransMedics Group
TransMedics Group's market capitalization is a financial expression of hope for a revolution in organ transplantation. Each rise on this chart reflects the successful application of its system for "reviving" donor organs, expanding the possibilities for saving lives. The scale of the market capitalization reflects investors' faith in the commercial potential of this unique technology.
TMDX - Share of the company's market capitalization TransMedics Group within the market segment - Specialized medical equipment
TransMedics is changing the rules of transplantation. Its market share reflects its status as a pioneer with its Organ Care system, which dramatically improves organ preservation. The company's market capitalization reflects investors' bet on its potential to become the new gold standard in this vital medical niche.
Market capitalization of the market segment - Specialized medical equipment
Here's a graph of the total value of the entire specialized medical equipment sector. For TransMedics, which created a revolutionary system for "reviving" donor organs, this line shows the scale of the potential market. The rising graph reflects both overall medical progress and investor confidence in technologies that could change the very nature of transplantation.
Market capitalization of all companies included in a broad market index - GURU.Markets
TransMedics Group is revolutionizing organ transplantation with its resuscitation systems. The company's market capitalization is the market valuation of a technology that offers a second chance at life. On a global scale, it represents the value of a breakthrough capable of transforming an entire field of medicine.
Book value capitalization of the company, segment and market as a whole
TMDX - Book value capitalization of the company TransMedics Group
TransMedics Group creates revolutionary equipment for organ transplants. The company's book value reflects its life-saving assets: production lines, patented organ perfusion systems, and R&D laboratories. Has the company increased its physical capital to expand its mission? The chart below shows.
TMDX - Share of the company's book capitalization TransMedics Group within the market segment - Specialized medical equipment
TransMedics Group is transforming transplantation, and its innovations are backed by real assets. The company produces portable organ perfusion systems—complex medical equipment. The chart shows the share of its production capacity and finished systems in the total physical assets of the specialized medical equipment sector.
Market segment balance sheet capitalization - Specialized medical equipment
Transplantation is a knowledge-intensive industry, but TransMedics makes it capital-intensive as well. The sector's asset chart demonstrates the industry's scale. TransMedics has created unique and expensive equipment for "reviving" donor organs; its business is the production and distribution of these systems.
Book value of all companies included in the broad market index - GURU.Markets
TransMedics revolutionized transplantation, and its assets are the technology itself. The company's book value is derived from its fleet of unique systems for reviving donor organs, as well as its manufacturing and logistics capabilities. The chart reflects the physical weight of this innovative medical equipment in the healthcare sector.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - TransMedics Group
TransMedics has created a revolutionary organ transportation system. Its balance sheet is the inventory of these devices. But the market doesn't value their production cost, but rather their potential to save thousands of lives and transform the transplant market. The graph shows a huge premium for this breakthrough, patent-protected technology.
Market to book capitalization ratio in a market segment - Specialized medical equipment
TransMedics Group is revolutionizing organ transplantation with its organ preservation system. The company's value is based on its life-saving potential and unique technology, not on its production capacity. The chart shows the enormous premium investors are paying for this medical breakthrough.
Market to book capitalization ratio for the market as a whole
TransMedics Group has developed a system for transporting donor organs, keeping them alive outside the body. The company's value lies in its unique, life-saving technology. This chart reflects overall market valuations, but how do investors value a medical company whose growth potential is based on revolutionizing the transplant process?
Debts of the company, segment and market as a whole
TMDX - Company debts TransMedics Group
TransMedics, a company with a unique organ transplant technology, is in a phase of rapid growth. Its financial strategy is focused on scaling the business. The capital raised, shown in this chart, is being used to expand production of medical systems and implement them in leading clinics worldwide.
Market segment debts - Specialized medical equipment
TransMedics Group has developed a revolutionary system for transporting donor organs that preserves their viability. Bringing such complex medical equipment to market requires enormous investments in research, approvals, and marketing. This chart shows how the company is funding its expansion within the medical technology sector.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio TransMedics Group
TransMedics Group has developed a revolutionary technology for organ donation. This chart shows the company's financial structure. For a medtech company at the commercialization stage of its product, borrowing may be necessary to scale production and marketing. The dynamics reflect the balance between investments in growth and the path to profitability.
Market segment debt to market segment book capitalization - Specialized medical equipment
Developing unique medical equipment for organ transplants, like TransMedics', requires massive investments in R&D and clinical trials. This chart illustrates the overall debt burden in the medical equipment sector. It helps us understand how TransMedics's financial model, at the forefront of innovation, compares to that of more established players in this market.
Debt to book value of all companies in the market
This chart shows the average debt level across the market. TransMedics develops unique medical equipment that requires significant investment in R&D and certification. A comparison with the overall figure, which includes non-tech companies, demonstrates how capital-intensive innovative activities in the medical field are compared to the average publicly traded company.
P/E of the company, segment and market as a whole
P/E - TransMedics Group
This chart for TransMedics, a developer of organ donor transportation systems, shows investor expectations. The high value, even with modest profits, reflects faith in the revolutionary nature of the technology and its potential to transform the transplant market. It's an estimate of the future cash flows the company could generate if its technology becomes standard.
P/E of the market segment - Specialized medical equipment
Transplantation, where TransMedics offers revolutionary technology, is a sector with enormous potential. This chart shows the average valuation for medical device companies. It helps us understand the enormous premium investors are paying for TransMedics' unique system, which could radically change the organ transplant process.
P/E of the market as a whole
TransMedics Group has developed a revolutionary technology for keeping donor organs (heart, lungs, liver) alive outside the body, significantly increasing their viability during transplantation. This chart reflects the overall risk appetite of investors. It helps us understand whether TMDX's high valuation is a result of faith in its unique technology or part of the overall optimism in the medical innovation sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company TransMedics Group
TransMedics Group has developed an innovative system for transporting donor organs that preserves their viability longer than traditional methods. This graph reflects market expectations for the implementation of this technology in medical practice. Its significance reflects the company's bet that the OCS system will become a new standard in transplantation and generate significant profits.
%20P%2FE%20TransMedics%20Group&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-TransMedics-Group&v=1772561883991 "Chart of the company's future (projected) P/E TransMedics Group")
Future (projected) P/E of the market segment - Specialized medical equipment
TransMedics Group revolutionized transplantation by creating a system for transporting donor organs that preserves their viability. This chart shows the company's expected future profitability compared to the medical equipment sector. Does the market appreciate its unique technology, which has the potential to change healthcare standards?
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772561884130 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
TransMedics Group has developed a revolutionary system for transporting donor organs while preserving their vitality. This is a breakthrough technology in medicine. The company's valuation depends not on general market sentiment, but on the speed of its system's implementation in hospitals and investors' confidence in changing the standard of transplantation.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772561884142 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit TransMedics Group
TransMedics Group is revolutionizing organ transplantation with its "organ-in-a-box" system, which keeps organs alive outside the body. The company's profitability depends on the number of hospitals implementing this expensive technology. This chart shows how successfully the company commercializes its innovations, turning medical breakthroughs into sustainable financial returns.
Profit of companies in the market segment - Specialized medical equipment
TransMedics Group has developed a revolutionary system for transporting donor organs that preserves their viability. This technology has the potential to transform the transplant market. This graph reflects overall profitability in the specialized medical equipment niche, where life-saving innovations can secure the company a dominant market position.
Overall market profit
TransMedics Group has developed a system for transporting donor organs that preserves their viability. The company's success depends on the implementation of its technology in hospitals. The overall economic situation, reflected in the graph, influences healthcare system budgets and their willingness to invest in costly innovations.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company TransMedics Group
TransMedics Group is revolutionizing transplantation with its system that keeps donor organs alive outside the body. The company's technology has the potential to fundamentally change medicine. This chart represents the analyst consensus forecast, which essentially assesses the likelihood of commercial success for this breakthrough medical innovation.
%20profit%20of%20the%20company%20TransMedics%20Group&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-TransMedics-Group&v=1772561884361 "Graph of future (projected) profit of the company TransMedics Group")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
TransMedics Group has developed an innovative system for transporting donor organs that preserves their viability longer than traditional methods. The company's technology has the potential to revolutionize transplantation. This chart shows profitability forecasts for the medical equipment sector, helping to assess the market's perception of the potential of breakthrough technologies like TMDX.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772561884380 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
TransMedics Group has developed a revolutionary technology for transporting donor organs. Demand for its system is determined solely by medical needs and the number of transplants, not by the state of the economy. This makes the company's business completely acyclical and unaffected by corporate profit forecasts, which investors see on this chart.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772561884420 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - TransMedics Group
TransMedics Group develops technologies for organ transplantation. This chart is critically important because it shows the enormous premium investors are paying for its revenue. This demonstrates strong faith in its revolutionary technology, which has the potential to transform the transplant market and set a new standard of care.
P/S market segment - Specialized medical equipment
TransMedics Group has developed an innovative system for preserving organs for transplantation, increasing their viability. This chart shows the average market value of revenue in the advanced medical equipment niche. It helps assess the premium investors are placing on the potential of TransMedics' technology to radically transform the transplant market.
P/S of the market as a whole
TransMedics Group has developed a revolutionary system for transporting donor organs, preserving their viability for longer. Their technology has the potential to transform transplantation. This chart provides an overview of market revenue estimates, which can be used to assess TMDX's potential and investor expectations for their breakthrough product.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company TransMedics Group
TransMedics Group has developed a revolutionary technology for transporting donor organs, maintaining their viability outside the body. This chart reflects investors' confidence in the commercial potential of this innovation. The company's valuation is based on projected future sales of its systems, which could radically change the field of transplantation.
%20P%2FS%20TransMedics%20Group&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-TransMedics-Group&v=1772561884630 "The graph of the company's future (projected) P/S TransMedics Group")
Future (projected) P/S of the market segment - Specialized medical equipment
TransMedics Group is changing the approach to organ transplantation with its Organ Care System (OCS), which preserves donor organs in a near-physiological state. This breakthrough technology is groundbreaking. This chart shows how investors assess its future sales potential compared to expectations for the specialized medical equipment industry as a whole.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772561884663 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
TransMedics Group has developed a revolutionary system for transporting donor organs while preserving their viability. This chart reflects overall investor sentiment and their willingness to invest in innovation. The rising price trend indicates optimism, which allows breakthrough companies like TransMedics to secure funding and expand the adoption of their technology in medical institutions.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772561884675 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales TransMedics Group
TransMedics Group has developed a revolutionary technology for transporting donor organs. This chart shows revenue from sales of the OCS (Organ Care System), which preserves organs for transplantation in a viable state. Growth indicates that more and more hospitals are implementing this technology, potentially saving countless lives.
Sales of companies in the market segment - Specialized medical equipment
TransMedics Group has developed a revolutionary technology for preserving the viability of donor organs (heart, lungs, liver) during transportation. The company's revenue can be broken down by organ type or geographic market. This chart shows the financial results of one of these segments, reflecting the progress in implementing this vital medical technology.
Overall market sales
TransMedics Group has revolutionized transplantation by creating a system for reviving donor organs. Its success is unrelated to general economic cycles, but rather depends on the implementation of breakthrough medical technologies. The company is creating a new market and saving lives, demonstrating how innovation in healthcare can generate enormous value regardless of trends.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company TransMedics Group
TransMedics Group has developed the revolutionary Organ Care System (OCS), which enables the preservation of donor organs (heart, lungs, liver) in a living, functioning state outside the body. The company's revenue forecast reflects the speed of adoption of this technology in transplantation. It demonstrates the market's confidence that OCS will become the new standard, increasing the number of successful transplants.
%20sales%20of%20the%20company%20TransMedics%20Group&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-TransMedics-Group&v=1772561884883 "Schedule of future (projected) sales of the company TransMedics Group")
Future (projected) sales of companies in the market segment - Specialized medical equipment
TransMedics Group has developed an innovative system for transporting donor organs, changing approaches to transplantation. This chart reflects revenue expectations for the entire specialized medical equipment sector. It helps understand the growth potential analysts see in new technologies that improve treatment outcomes and expand the medical services market.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772561884910 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
TransMedics Group, with its organ donation technology, operates in the high-tech medical sector. The company's growth depends on hospitals' ability to invest in expensive equipment. This graph of overall sales forecasts reflects the overall economic situation, which impacts healthcare budgets and innovation.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772561885010 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality TransMedics Group
TransMedics Group has developed a revolutionary system for transporting donor organs that maintains their viability outside the body. This is a breakthrough technology in transplantation. This chart shows how the company converts revenue from the sale of its expensive systems and services into profit, balancing production costs with massive investments in R&D.
Market segment marginality - Specialized medical equipment
TransMedics Group has developed a revolutionary system for transporting donor organs (heart, lungs, liver) that maintains their function outside the body. This technology significantly increases the chances of a successful transplant. This graph illustrates the potential cost-effectiveness of this breakthrough medical technology, which is creating a new market niche.
Market marginality as a whole
TransMedics Group has revolutionized transplantation with its donor organ transportation system. The company's profitability depends on the adoption of its technology in hospitals and the volume of transplants. This chart shows the overall profitability, but for TMDX, growth is driven by a unique medical innovation that solves a critical problem in healthcare.
Employees in the company, segment and market as a whole
Number of employees in the company TransMedics Group
TransMedics Group has developed a revolutionary system for transporting donor organs. This chart shows the growth of its team of specialists supporting the implementation of this technology in hospitals. This growth reflects the rapid adoption of this new, life-saving standard in transplantation.
Share of the company's employees TransMedics Group within the market segment - Specialized medical equipment
TransMedics Group has developed revolutionary technology for organ donation. Its success depends on the team of clinical specialists who support each transplant. This chart shows its share of employers in the advanced medical device sector, reflecting its contribution to saving lives.
Number of employees in the market segment - Specialized medical equipment
TransMedics Group has developed a revolutionary technology for organ donation. This chart shows employment in the specialized medical equipment sector. The growing number of professionals in this field demonstrates the active implementation of innovation in healthcare, creating fertile ground for widespread adoption of TransMedics' breakthrough system.
Number of employees in the market as a whole
TransMedics Group, with its revolutionary organ transplant technology, depends on the state of the healthcare system. A strong economy with high employment, as shown in this chart, means hospitals have more resources to purchase innovative equipment, and patients have insurance that covers advanced medical procedures.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company TransMedics Group (TMDX)
TransMedics Group has developed a revolutionary system for transporting donor organs while maintaining their viability. The very high value on this chart indicates that the market views the company not as an equipment manufacturer, but as the creator of a unique technology capable of saving lives. The value here is in its intellectual property and the potential to transform medicine.
%20of%20the%20company%20TransMedics%20Group%20(TMDX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-TransMedics-Group-TMDX&v=1772561885380 "Chart of market capitalization per employee (in thousands of dollars) of the company TransMedics Group (TMDX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
TransMedics (TMDX) is a game-changing MedTech company. It created the "OCS"—an "organ-in-a-box" that revives donor organs. It's a hybrid of hardware (the machine) and service (the logistics). This chart shows the market price per employee in this revolutionary, high-touch medical model.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772561885410 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
TransMedics Group has developed a revolutionary system for transporting donor organs while preserving their viability. This is a breakthrough medical technology capable of saving lives. The chart reflects the enormous value the market places on the intellectual property and potential of the company, built by a small team of specialists.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772561885466 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company TransMedics Group (TMDX)
TransMedics Group has revolutionized organ transplantation with its Organ Care System (OCS), which keeps organs alive outside the body. It's a breakthrough medical technology. This graph shows how effectively their highly specialized team (engineers, clinicians, and logisticians) manages this complex and expensive service. It measures the ability to monetize this life-saving technology.
%20Chart%20TransMedics%20Group%20(TMDX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-TransMedics-Group-TMDX&v=1772561885524 "Company Profit Per Employee (in thousands of dollars) Chart TransMedics Group (TMDX)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
TransMedics (TMDX) is a medtech company that created an "OCS" (organ-in-a-box) for "reviving" donor organs (hearts, lungs). This chart shows the benchmark for "Specialized Medical Equipment." In this sector, the benchmark is *very* high. It's a "razor-and-blade" model: profit is generated by the "consumables" needed for each transplant.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772561885534 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
TransMedics (TMDX) is revolutionizing transplantation. They created the Organ Care System (OCS)—a portable device that keeps donor organs (heart, lungs, liver) alive outside the body. This graph, showing average profit per employee across the market, helps us understand how the high-tech medical equipment sector, where R&D and engineers create high added value, outperforms the average labor efficiency.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772561885564 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee TransMedics Group (TMDX)
TransMedics Group has developed a revolutionary system for organ donation. This graph demonstrates how an innovative product can generate significant revenue. This growth reflects the successful implementation of the technology into medical practice, enabling a small team to provide a vital service with high added value.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-TransMedics-Group-TMDX&v=1772561885642 "Sales chart per company employee TransMedics Group (TMDX)")
Sales per employee in the market segment - Specialized medical equipment
TransMedics is revolutionizing transplantation with its OCS system, which "revitalizes" organs for transport. It's a niche, high-tech business. This graph shows the effectiveness of their business model: how much revenue each employee generates compared to the average for the medical equipment industry. This helps assess the success of their unique product in the market.
Sales per employee for the market as a whole
TransMedics Group revolutionized transplantation by creating the Organ Care System (OCS)—portable devices that keep organs (heart and lungs) alive outside the body. This breakthrough medical technology is a breakthrough. This graph shows the company's revenue generated per employee from the sale or lease of these expensive systems, as well as their support services.
Short shares by company, segment and market as a whole
Shares shorted by company TransMedics Group (TMDX)
TransMedics revolutionized transplantation with its Warm Perfusion System (OCS), which keeps organs alive outside the body. It's a breakthrough technology. However, the company is still proving its economic feasibility to the market and struggling for widespread adoption in hospitals. This chart shows the number of investors who consider the stock overhyped and doubt the speed of commercialization.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-TransMedics-Group-TMDX&v=1772561885771 "Short Shares Chart for the Company TransMedics Group (TMDX)")
Shares shorted by market segment - Specialized medical equipment
TransMedics Group revolutionized transplantation with the creation of the Organ Care System (OCS)—a portable device that keeps donor organs (heart, lungs, liver) alive outside the body. This chart shows the odds against the specialized medical equipment sector, reflecting investor skepticism about the pace of adoption of this new, expensive technology.
Shares shorted by the overall market
TransMedics (TMDX) has created an "organ-in-a-box" system for transplants. It's a breakthrough technology. This indicator (`Short_All`) is a mirror of market fear. When it rises, investors panic and dump unprofitable growth stocks. This pessimism, visible on the chart, weighs on TMDX, despite its medical potential.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator TransMedics Group (TMDX)
TransMedics has developed a system for transporting donor organs (the "heart-in-a-box"). Its business depends on hospitals adopting the technology. A TMDX chart above 70 may reflect strong growth in procedures. A level below 30 may reflect concerns about slowing growth or reimbursement issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-TransMedics-Group-TMDX&v=1772561885898 "RSI 14 indicator chart for the company's stock TransMedics Group (TMDX)")
RSI 14 Market Segment - Specialized medical equipment
TransMedics (TMDX) is "living" organs. They "hacked" transplantation by creating the "OCS"—a "box" that "perfuses" (pumps blood) into a donor heart or liver *outside* the body. This metric measures the "temperature" of the sector. It helps us understand: is TMDX "overheated" by its "revolutionary" technology, or is the entire medical equipment sector "overbought"?
RSI 14 for the overall market
TransMedics (TMDX) offers systems for transporting donor organs. This chart reflects the willingness of hospitals and investors to implement expensive innovations. During periods of market euphoria, biotech receives generous funding. During times of panic, even despite the vital importance of the technology, the focus shifts to cost, which may slow the adoption of TMDX systems.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TMDX (TransMedics Group)
TransMedics Group revolutionized transplantation with the creation of the Organ Care System (OCS). This technology allows donor organs (heart, lungs, liver) to be kept alive outside the body, improving their viability. This chart shows the average analyst forecast, based on the pace of OCS adoption in hospitals and the expansion of indications for its use.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TMDX-TransMedics-Group&v=1772561886035 "A chart showing analyst consensus forecasts for the expected stock price. TMDX (TransMedics Group)")
The difference between the consensus estimate and the actual stock price TMDX (TransMedics Group)
TransMedics (TMDX) has created a revolutionary OCS (organ-in-a-box) system that allows donor hearts, lungs, and livers to be kept alive outside the body, expanding the transplant window. This chart demonstrates their faith in their technology. It measures the gap between the price and the consensus target, reflecting the enormous potential analysts see in this technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TMDX-TransMedics-Group&v=1772561886058 "A chart showing the difference between the consensus forecast and the actual stock price. TMDX (TransMedics Group)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
TransMedics (TMDX) is changing the rules of transplantation. It has created a "living container" (OCS) that "pumps" donor organs (hearts, lungs), preserving their viability. This chart shows general expectations for the medical equipment sector. It reflects whether experts believe this technology will become the new standard.
Analysts' consensus forecast for the overall market share price
TransMedics Group revolutionized transplantation with the creation of the Organ Care System (OCS)—a portable system that keeps organs (heart, lungs, liver) alive outside the body. This chart shows the overall risk appetite. For TransMedics, a fast-growing medical company changing the standard of care, overall optimism is essential to supporting the high valuation needed to fund growth and research.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index TransMedics Group
TransMedics Group has revolutionized transplantation. They created the Organ Care System (OCS)—a portable system that revives donor organs (heart, lungs, liver) outside the body, keeping them warm and functional. This graph is an assessment of their breakthrough technology. It measures the rate of adoption of their system in hospitals, enabling more organs to be used and more lives to be saved.
AKIMA Market Segment Index - Specialized medical equipment
TransMedics is a revolutionary in transplantation; the company has created the OCS (Organ in a Box) system, a portable system that doesn't freeze organs (heart, lungs) but keeps them alive (warm), increasing their availability. This composite metric evaluates companies. The graph shows the average value for the sector. This benchmark: how does this breakthrough TMDX technology differentiate it from the average competitor?
The AKIM Index for the overall market
TransMedics is an organ in a box. The company has revolutionized transplantation: its OCS system maintains life (perfusion) in donor organs (hearts, lungs) during transport. This chart, reflecting the market average, is the backdrop. It helps to assess how this disruptive story in the protective sector fits into the overall macroeconomic picture.
